B-type natriuretic peptide (BNP) is a quantitative marker for heart failure. The use of BNP in patients with dyspnea has consistently shown to improve patient management and reduce treatment cost. Additional indications with the potential to improve patient management include treatment monitoring in acute and chronic heart failure, pulmonary embolism, and coronary artery disease.
显示更多 [+] 显示较少 [-]AGROVOC关键词
书目信息
出版者
Blackwell Publishing Ltd
其它主题
Cost; Praćenje; Bnp; Dyspnea; Heart failure; Troškovi; Srčana bolest
语言
英语
类型
Journal Article; Text
2024-02-27
2026-02-03
MODS